Literature DB >> 2961514

Human atrial natriuretic peptide secretion in precapillary pulmonary hypertension. Clinical study in patients with COPD and interstitial fibrosis.

O C Burghuber1, E Hartter, C Punzengruber, M Weissel, W Woloszczuk.   

Abstract

Human atrial natriuretic peptide (hANP) is stored by granules of both human atria. Atrial distension appears to be a major stimulus for hANP secretion. Precapillary pulmonary hypertension increases right ventricular afterload and may thus cause right atrial distension. We therefore hypothesized that hANP plasma concentrations (1) are higher in the right atrium than in the peripheral vein, (2) are increased in patients with precapillary pulmonary hypertension, and (3) correlate with right atrial pressure. Thirty-three adult patients with chronic obstructive pulmonary disease (COPD) or interstitial fibrosis were examined by right heart catheterization. Mean pressures were measured in the right atrium, pulmonary artery, and pulmonary capillary wedge position, and blood was drawn from the right atrium and from a peripheral vein for determination of hANP levels. In general, hANP plasma levels in the right atrium were significantly higher than in a peripheral vein. Seventeen out of 33 patients had pulmonary hypertension, whereas 16 patients exhibited normal pulmonary artery mean pressures. In all patients, pulmonary arterial wedge pressure was normal. Plasma hANP concentrations were significantly higher in patients with pulmonary hypertension than in patients with normal pulmonary artery pressure. A strong correlation between central or peripheral hANP plasma levels (or both) and mean right atrial pressure could be observed (r = 0.75; p less than 0.001). From these data, we conclude that the increased secretion of hANP in our patients with precapillary pulmonary hypertension appears to be mediated by right atrial distension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2961514     DOI: 10.1378/chest.93.1.31

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Humoral control of airway tone.

Authors:  N C Thomson; K D Dagg; S G Ramsay
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

2.  Urinary cGMP concentrations in severe primary pulmonary hypertension.

Authors:  M Bogdan; M Humbert; J Francoual; C Claise; P Duroux; G Simonneau; A Lindenbaum
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

3.  Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease.

Authors:  K Skwarski; M Lee; L Turnbull; W MacNee
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

4.  Normotensive normoxic men undergoing water diuresis fail to respond to stimulation of their peripheral arterial chemoreceptors by almitrine with an increase in plasma concentrations of atrial natriuretic factor.

Authors:  C Ledderhos; W Quies; A Bub; R Sanchez
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

5.  Atrial natriuretic peptide concentrations in children with pulmonary hypertension: correlation with hemodynamic measurements.

Authors:  F S Tunaoglu; F R Olgunturk; N Gokcora; C Turkyilmaz; F Gurbuz
Journal:  Pediatr Cardiol       Date:  1994 Nov-Dec       Impact factor: 1.655

6.  Raised circulating plasma levels of atrial natriuretic peptide in adolescent and adult patients with cystic fibrosis and pulmonary artery hypertension.

Authors:  O C Burghuber; E Hartter; M Weissel; W Wolosczcuk; M Götz
Journal:  Lung       Date:  1991       Impact factor: 2.584

7.  Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.

Authors:  R S Baliga; C J Scotton; S L Trinder; R C Chambers; R J MacAllister; A J Hobbs
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.